[Menopause: Hypertension and Vascular Disease]
Overview
Authors
Affiliations
Hypertension is the main cardiovascular risk factor affecting 25% of women. Hormone changes and hypertension after menopause may lead to higher target organ damage and cardiovascular disease such as increased arterial stiffness, coronary diseases, chronic heart failure and stroke. The physiopathological mechanisms involved in the development of hypertension and cardiovascular diseases in menopausal women are controversial. There are pharmacokinetic and pharmacodynamic differences in both sexes, the women have more coughing when using the converting-enzyme inhibitors, more cramps when using thiazide diuretics and more oedema in the inferior limbs when using calcium antagonists. The aim of this review is to analyse possible physiopathological mechanisms involved in hypertension after menopause and to gain a better understanding of the biological effects mediated by vascular ageing in women when the level of oestrogen protective effect decreases over the vascular system.
Li Z, Guo J, Huang L BMC Womens Health. 2024; 24(1):215.
PMID: 38570811 PMC: 10988979. DOI: 10.1186/s12905-024-03056-5.
Shamsuddin S, Davis K, Moorhouse L, Mandizvidza P, Maswera R, Dadirai T Open Heart. 2023; 10(1).
PMID: 37385733 PMC: 10314626. DOI: 10.1136/openhrt-2023-002346.
Sanchez-Delgado J, Jacome-Hortua A, Uribe-Sarmiento O, Philbois S, Pereira A, Rodrigues K Braz J Med Biol Res. 2023; 56:e12241.
PMID: 37194832 PMC: 10241482. DOI: 10.1590/1414-431X2023e12241.
Estrogen normalizes maternal HFD-induced vascular dysfunction in offspring by regulating ATR.
Chen F, Zhao R, Zhang H, Huang C, Liu Y, Xue Q Hypertens Res. 2022; 45(11):1743-1753.
PMID: 35999282 DOI: 10.1038/s41440-022-01002-2.
Gut Microbes in Gynecologic Cancers: Causes or Biomarkers and Therapeutic Potential.
Han M, Wang N, Han W, Ban M, Sun T, Xu J Front Oncol. 2022; 12:902695.
PMID: 35912194 PMC: 9326394. DOI: 10.3389/fonc.2022.902695.